source
- MacroGenics sells manufacturing operations to Bora for $122.5M; West Pharma reports cybersecurity breachMacroGenics announced it is selling its clinical and commercial drug substance manufacturing portfolio to CDMO Bora. The deal includes an upfront payment of $122.5 million. The transaction transfe…
- In vivo CAR-T therapies dominate talks at ASGCT 2026 conferenceThe reporter is on the ground in Boston covering the American Society of Gene & Cell Therapy's annual meeting. Sessions across the conference are highlighting in vivo CAR-T approaches, showing tha…